But its not just midlife women
Zepbound, the obesity-indication version of tirzepatide, added $5.7 billion in H1 2025, a product that was not launched until late 2023 and is now available in a multi-dose KwikPen
#NutritionScience #CheeseLovers #HealthMyths #EvidenceBasedNutrition #FoodScience #HealthyEating # To view or add a comment, sign in Healthy food alone isn't enough Absorption is the real differentiator This image isn't about food tips
If you'll be gone for several hours, pack snacks that help keep you consistent
What Changed in 2026 That Every GLP-1 Patch Buyer Should Know In January 2026, the FDA approved the first oral semaglutide tablet for weight management - a Wegovy pill that works without injections or needles
Roasted Sesame Chicken and Balsamic Broccoli Salad (from HFLM!) The balsamic sesame garlic dressing in this meal makes eating protein and fiber so enjoyable